Cite
Fu X, Chen G, Cai ZD, et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. Onco Targets Ther. 2016;9:2211-20doi: 10.2147/OTT.S101994.
Fu, X., Chen, G., Cai, Z. D., Wang, C., Liu, Z. Z., Lin, Z. Y., Wu, Y. D., Liang, Y. X., Han, Z. D., Liu, J. C., & Zhong, W. D. (2016). Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. OncoTargets and therapy, 92211-20. https://doi.org/10.2147/OTT.S101994
Fu, Xin, et al. "Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer." OncoTargets and therapy vol. 9 (2016): 2211-20. doi: https://doi.org/10.2147/OTT.S101994
Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. Onco Targets Ther. 2016 Apr 15;9:2211-20. doi: 10.2147/OTT.S101994. eCollection 2016. PMID: 27143916; PMCID: PMC4844448.
Copy
Download .nbib